Product Information
LIALDA DR 1.2 GM TABLET is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $8.9467 per EA under NDC 54092047612. Its NADAC has been published 657 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the mesalamine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1.2 g/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
54092047612
Classification
Brand
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MESALAMINEApproval Type
New Drug (NDA)
FDA Application
NDA022000On Market Since
1/16/2007
Pharmacological Classes
Price Statistics
The NADAC for LIALDA DR 1.2 GM TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 45.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.9467 per EA |
|---|---|
| All-time high | $9.0779 (Dec 14, 2022) |
| All-time low | $6.1316 (Nov 28, 2013) |
| 52-week high | $8.9844 |
| 52-week low | $8.9467 |
| Median price | $8.9747 |
| Average price | $8.4872 |
| Largest weekly change | +9.0% (Jun 14, 2017) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 91% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LIALDA DR 1.2 GM TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LIALDA DR 1.2 GM TABLET, manufactured by Takeda Pharmaceuticals America, Inc., is $8.9467 per EA (NDC 54092047612), effective Jun 24, 2026.
How has the price of LIALDA DR 1.2 GM TABLET changed over time?
Over the history we have for it, the NADAC for LIALDA DR 1.2 GM TABLET has risen 45.9%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LIALDA DR 1.2 GM TABLET?
Since Nov 28, 2013, the NADAC for LIALDA DR 1.2 GM TABLET has ranged from a low of $6.1316 (Nov 28, 2013) to a high of $9.0779 (Dec 14, 2022), with a median of $8.9747 per EA.
Are there cheaper alternatives to LIALDA DR 1.2 GM TABLET?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, MESALAMINE DR 1.2 GM TABLET, is $0.8138 per EA — about 91% below LIALDA DR 1.2 GM TABLET.
Who manufactures LIALDA DR 1.2 GM TABLET?
LIALDA DR 1.2 GM TABLET (NDC 54092047612) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.